August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Daniel Auclair: Impressive Early Data Presented at EHA2025 for JNJ’4496 Dual CD19/CD20 CART in R/R LBCL
Jun 15, 2025, 08:11

Daniel Auclair: Impressive Early Data Presented at EHA2025 for JNJ’4496 Dual CD19/CD20 CART in R/R LBCL

Daniel Auclair, President at Hematocure, LLC shared a post on X:

“Impressive early data presented for JNJ’4496 dual CD19/CD20 CART in R/R LBCL at EHA2025. 100% ORR and 80% CR at RP2D. No Gr. 3/4 CRS to date, no prophylactic therapy for ICANS or CRS.”

EHA2025

More posts featuring EHA 2025 on OncoDaily.